US Procalcitonin Market Insight
US procalcitonin market size is growing at a 6.80% CAGR, driven by increasing prevalence of bacterial infections and sepsis, rising demand for rapid diagnostic biomarkers
US Procalcitonin Market Insights Forecasts to 2035
- The US Procalcitonin Market Size Was Estimated at USD 420.0 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.80% from 2025 to 2035
- The US Procalcitonin Market Size is Expected to Reach USD 810.0 Million by 2035
Notable Insights for US Procalcitonin Market
- By product type, assay kits dominated the market, generating approximately USD 200.0 Million in revenue in 2024 due to widespread use in hospital laboratories and diagnostic centers.
- By application, sepsis diagnosis is expected to witness the fastest growth, supported by increasing awareness and need for early detection of life-threatening infections.
- Approximately 70% of demand is driven by hospitals and diagnostic laboratories, while nearly 56% growth is supported by advancements in immunoassay technologies and increasing focus on accurate and rapid diagnostics. Additionally, rising healthcare expenditure in the US is supporting market expansion.
- Growing prevalence of infectious diseases, increasing adoption of biomarker-based diagnostics, and advancements in clinical testing technologies are driving market growth.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US Procalcitonin market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in US Procalcitonin Market
- Thermo Fisher Scientific Inc.
- bioMérieux SA
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Danaher Corporation
- Diasorin S.p.A.
- Others
Recent Developments:
- In October 2025, Thermo Fisher Scientific Inc. expanded its diagnostic portfolio with advanced procalcitonin testing solutions.
- In June 2024, Roche Diagnostics introduced improved immunoassay systems for rapid infection diagnosis.
Market Segmentation:
US Procalcitonin Market, By Product Type
- Assay Kits
- Analyzers
- Reagents
US Procalcitonin Market, By Application
- Sepsis Diagnosis
- Respiratory Infections
- Antibiotic Stewardship
- Others
US Procalcitonin Market, By End User
- Hospitals
- Diagnostic Laboratories
- Research Institutes
Expert Views:
The US Procalcitonin Market is expected to witness steady growth, driven by increasing demand for early and accurate infection diagnosis. Experts highlight that advancements in biomarker research, growing focus on antimicrobial stewardship, and integration of rapid diagnostic technologies will shape future market trends.